Given the central role for MYCN and its target genes in high-risk neuroblastoma, the abrupt and potent depletion of MYCN upon HIF2α induction strongly argues against an oncogenic role for HIF2α in this particular disease. This evidence concerns the gene MYCN and neuroblastoma.